CrushSCI.com
139.9Average days
85.5Median days
53Fastest days
412Longest days
5772025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

53 days

Symptom clusters and quality of life among patients with thyroid cancer during early survivorship: a national multicenter cross-sectional study

Authors
Jie Gao; Xin Wang; Jiayan Cao; Yanyan Chen; Yi Tu; Xiaohua Song; Yingchun Zhou; Duo Tao; Lianjie Zhang; Jing ZhaoShow moreShow less
Affiliations
1. Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy , Tianjin 300060,; 2. The Third Clinical Medical College of Xinjiang Medical University , Urumqi, 830011,; 3. Xinjiang Uygur Autonomous Region , Urumqi, 830011,; 4. Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou, Zhejiang 310022,; 5. Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , Changsha, Hunan 410000,; 6. Chongqing University Cancer Hospital, Chongqing Cancer Research Institute , Chongqing 400030,; 7. Sun Yat-sen Memorial Hospital, Sun Yat-sen University , Guangzhou, Guangdong 510120,; 8. The First Bethune Hospital of Jilin University , Changchun, Jilin 130031,Show moreShow less
Source PDF DOI Publisher page
53 days

Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101)

Authors
Takaaki Tanaka; Go Makimoto; Naoki Nakamura; Yuka Kato; Isao Oze; Toshihide Yokoyama; Shoichi Kuyama; Satoru Senoo; Koji Inoue; Hirohisa Ichikawa; Yoshinobu Maeda; Yosuke Togashi; Katsuyuki HottaShow moreShow less
Affiliations
1. Department of Hematology, Oncology and Respiratory Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558,; 2. Department of Respiratory Medicine, Okayama University Hospital , Okayama 700-8558,; 3. Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center , Ehime 791-0280,; 4. Division of Cancer Information and Control, Aichi Cancer Center Research Institute , Nagoya 464-8681,; 5. Department of Respiratory Medicine, Kurashiki Central Hospital , Okayama 710-8602,; 6. Department of Respiratory Medicine, Iwakuni Clinical Center , Yamaguchi 740-8510,; 7. Department of Respiratory Medicine, NHO Fukuyama Medical Center , Hiroshima 720-8520,; 8. Department of Respiratory Medicine, Ehime Prefectural Central Hospital , Ehime 790-0024,; 9. Department of Respiratory Medicine, KKR Takamatsu Hospital , Kagawa 760-0018,; 10. Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558,; 11. Advanced Research Field, Institute for Emerging Medical Innovation, Okayama University Hospital , Okayama 700-8558,; 12. Kindai University, Faculty of Medicine , Osaka 590-0197,; 13. Center for Innovative Clinical Medicine, Okayama University Hospital , Okayama 700-8558,Show moreShow less
Source PDF DOI Publisher page
154 days

Global management of drug–drug interaction in patients with prostate cancer: international survey by Meet-URO group and ONCOassist

Authors
Anna Amela Valsecchi; Michele Maffezzoli; Maria Concetta Cursano; Mattia Di Civita; Fiorenza Santamaria; Stefania Kingspergher; Elisa Zanardi; Giuseppe Procopio; Suleka Ashok; Lakshmi Ramachandran; Renita George; Kevin Bambury; Richard Bambury; Eoin O’Carroll; Giuseppe Luigi Banna; Massimo Di Maio; Daniele SantiniShow moreShow less
Affiliations
1. Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, 10126,; 2. Oncology Unit, University Hospital of Parma, Parma, 43126,; 3. Department of Oncology, Ospedale Ca’ Foncello, Treviso, 31100,; 4. Department of Experimental Medicine, Sapienza University of Rome , Rome, 00161,; 5. Department of Medical Oncology, Medical Oncology Unit, Sandro Pertini Hospital , Rome, 00157,; 6. Ospedale San Maurizio , Bolzano, 39100,; 7. UO Clinica di Oncologia Medica, IRCCS Azienda Ospedaliera Metropolitana , Genoa, 16132,; 8. Department of Oncology, Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milano , Milan, 20133,; 9. ONCOassist , V93 T8K7,; 10. Portsmouth Hospitals University NHS Trust , Portsmouth, PO6 3LY,; 11. Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth , Portsmouth, PO1 2UP,; 12. Department of Sciences and Medical-Surgery Biotechnologies, La Sapienza, Università di Roma , Rome, 04100,Show moreShow less
Source PDF DOI Publisher page
61 days

The insufficient publication of early-phase clinical trials in oncology

Authors
Merel J J Lucassen; Tim Schutte; Alwin D R Huitema; Neeltje SteeghsShow moreShow less
Affiliations
1. Department of Medical Oncology, The Netherlands Cancer Institute , Amsterdam, 1066 CX,; 2. Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute , Amsterdam, 1066 CX,; 3. Department of Pharmacology, Princess Máxima Center for Pediatric Oncology , Utrecht, 3584 CS,; 4. Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University , Utrecht, 3584 CX,; 5. Department of Medical Oncology, University Medical Center Utrecht, Utrecht University , Utrecht, 3584 CX,Show moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.